Lapo Alinari, MD, PhD
Researcher Spotlight: Lapo Alinari, MD, PhD The Ohio State University Dr. Alinari’s Lymphoma Clinical Research Mentoring Program (LCRMP) project investigates the combination of ibrutinib (Imbruvica) and nivolumab (Opdivo) in relapsed or refractory Hodgkin lymphoma (HL) patients. Nivolumab, a PD-1 checkpoint…